Tech Daily Utah: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Daily Utah.

Press releases published on June 22, 2026

15 hours ago

Annual General Meeting of Shareholders to Be Held on September 9, 2026 and Adoption of Advance Notice By-Law

Indeterminate GlobeNewswire

18 hours ago

Telix Educational Webinar: Neuro-Oncology Portfolio Update and Physician Perspectives on Future Therapeutic Directions

Indeterminate GlobeNewswire

18 hours ago

Cronos Group Inc. Announces Results of 2026 Annual Meeting of Shareholders

Indeterminate GlobeNewswire

18 hours ago

Pioneering screening test offers potential to find more aggressive prostate cancers

Indeterminate GlobeNewswire

18 hours ago

20/20 BioLabs Announces Monthly Investor Webinar Series to be Held on the First Wednesday of Each Month

Indeterminate GlobeNewswire

18 hours ago

MacroGenics to Receive Milestone Payment from Sanofi for Recent TZIELD® Approval

Indeterminate GlobeNewswire

Jun. 22, 2026

Elevar Therapeutics Announces First Patients Dosed in Phase 2 Study of Lirafugratinib Among Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement

Indeterminate GlobeNewswire

Jun. 22, 2026

i10X launches Superagent

Indeterminate GlobeNewswire

Jun. 22, 2026

IMUNON to Present at the Life Sciences Investor Forum on June 25th

Indeterminate GlobeNewswire

Jun. 22, 2026

Dyne Therapeutics Appoints Barry Greene to Board of Directors

Indeterminate GlobeNewswire

Jun. 22, 2026

TECfusions’ Simon Tusha Participates in Nasdaq Global Industrials Forum, Highlighting the Critical Role of Data Centers in the AI Economy

Indeterminate GlobeNewswire

Jun. 22, 2026

Acquisition of Centessa by Lilly Approved by the High Court of Justice of England and Wales

Indeterminate GlobeNewswire

Jun. 22, 2026

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 22, 2026

CervoMed Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Indeterminate GlobeNewswire

Jun. 22, 2026

Tango Therapeutics Appoints Robert Azelby to Board of Directors

Indeterminate GlobeNewswire

Jun. 22, 2026

Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 22, 2026

Vivani Medical CEO Adam Mendelsohn to Present at the 2026 BIO International Convention

Indeterminate GlobeNewswire

Jun. 22, 2026

MoonLake Immunotherapeutics Announces Proposed Public Offering

Indeterminate GlobeNewswire

Jun. 22, 2026

Beyond Air Schedules Fiscal Year End 2026 Financial Results Conference Call and Webcast

Indeterminate GlobeNewswire

Jun. 22, 2026

uniQure Announces $150 Million Proposed Public Offering

Indeterminate GlobeNewswire